Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · RxSight, Inc. (RXST)

RxSight Q3 revenue falls 19% to $24.6 million as net loss widens to $16.2 million

Negative Impact 3 of 5 earnings Written later

RxSight reported third quarter 2026 results for the period ended September 30, 2026, with total revenue down 19% from the prior-year quarter, primarily reflecting ongoing competitive pressures. The net loss widened to $16.2 million, or $0.39 per share, from $9.8 million, or $0.24 per share, a year earlier, and gross margin fell to 73.6% from 79.9%. Shareholders also get a company that ended the quarter with $254.7 million in cash and short-term investments, including $60 million received in connection with the Alcon collaboration.

Key points

  • Third quarter total revenue was $24.6 million, down 19% from $30.3 million a year earlier; the filing cites ongoing competitive pressures.
  • Net loss was $16.2 million, or $0.39 per share, versus $9.8 million, or $0.24 per share, in the third quarter of 2025.
  • Gross margin was 73.6%, compared with 79.9%, reflecting higher inventory reserves and higher inventory costs.
  • Cash, cash equivalents and short-term investments totaled $254.7 million as of September 30, 2026; the company also appointed Taryn Conway as Chief Commercial Officer.

The filing

CompanyRxSight, Inc. (RXST)
Form8-K, current report
Filed with the SECNov 3, 2026, 4:05 PM ET
Accession number0001193125-26-445318

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 03, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.